Minimally-Invasive CRS/HIPEC: Could it Revolutionize Mesothelioma Surgery?
A new study out of Spain suggests that it might be possible to perform the surgery that has become the standard of care for peritoneal mesothelioma in a much less invasive way. Cytoreductive surgery with heated intraperitoneal chemotherapy (CRS/HIPEC) has dramatically changed the survival odds for people with the abdominal form of malignant mesothelioma, also known as asbestos cancer. Now, researchers at the University Hospital Reina Sofia in Cordoba, Spain say they have successfully performed this extensive multi-part procedure through tiny incisions using an internal camera for guidance. After treating eight abdominal cancer patients this way—including two with a benign form of peritoneal mesothelioma—the research team concludes that this minimally invasive mesothelioma surgery approach is “feasible and safe” in the…